Clinical Trial Update: A Trial of HRS-8427 in the Treatment of Adults With Complicated Urinary Tract Infection, Including Acute Pyelonephritis [Phase 3]

View source ↗

Summary

HRS-8427 is being evaluated in a Phase 3 trial for adults with complicated urinary tract infection, including acute pyelonephritis, and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Pyelonephritis

Drugs mentioned

• HRS-8427

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP) | Phase 3 | Status: RECRUITING